Skip to content

Pan-Hematology Clinical Updates

A Review of the Treatment Landscape 2026

📍 Hilton Garden Inn San Juan Condado, 886 Ashford Ave, San Juan, 00907, Puerto Rico

🗓️ February 12 - 14, 2026

Dear Colleagues and Friends,

We are delighted to extend our warmest invitation to the Pan-Hematology Clinical Updates Review 2026, to be held at on February 12 - 14, 2026.

Centered around the theme “Updating Knowledge & Clinical Practice in 2026” this meeting provides pivotal collaboration aimed at advancing Pan-Hematology research and patient treatment.

This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.

Chairs of Pan-Hematology Clinical Updates Meeting 2026:

Naval-Daver

Naval Daver, MD
MD Anderson Cancer Center, Houston, TX

Christopher-Flowers

Christopher Flowers, MD
MD Anderson Cancer Center, Houston, TX

RK

Rami Komrokji, MD
Moffitt Cancer Center, Tampa, FL

Elias-Jabbour

Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX

Noopur-Raje

Noopur Raje, MD
Massachusetts General Hospital, Boston, MA

Supporters to be announced...
Interested in supporting this meeting? Get in contact:
olivia.wright@md-education.com

Agenda & Faculty

February 12, 2026 | Day 1  

8:00 AM
Registration Opens

Session I: Updates in Targeted Therapies in AML
Moderated by:

Naval-Daver

Naval Daver, MD
MD Anderson Cancer Center, Houston, TX

9:00 AM
IDH Mutated AML Updates
 
Uma-Borate
Uma Borate, MD
The Ohio State University, Ohio
9:15 AM
FLT3 Mutated AML Updates
 
Alexander-Perl
Alexander Perl, MD
Perelman School of Medicine, Philadelphia, PA
9:30 AM
Menin Inhibitor AML Updates
 
Joshua-Zeidner-1
Joshua Zeidner, MD
UNC School of Medicine, Chapel Hill, NC
9:45 AM
Panel Discussion
10:30 AM
Coffee Break

Session II: Updates in Optimizing Frontline Therapy in Myeloid Malignancies
Moderated by:

Naval-Daver

Naval Daver, MD
MD Anderson Cancer Center, Houston, TX

10:50 AM
Intensive Chemotherapy Updates
 
Tapan-Kadia
Tapan Kadia, MD
MD Anderson Cancer Center, Houston, TX

11:05 AM
Low Intensity Therapy Updates
 
Eunice-Wang
Eunice Wang, MD
Roswell Park Comprehensive Cancer Center, Buffalo, NY
11:05 AM
BPDCN Updates
 
Naveen-Pemmaraju
Naveen Pemmaraju, MD
MD Anderson Cancer Center, Houston, TX
 
11:35 AM
Panel Discussion
12:20 PM
Lunch Break + Faculty and Fellow Photo

Session III: Updates on Upfront Therapies and CELMoDs
Moderated by:

Noopur-Raje

Noopur Raje, MD
Massachusetts General Hospital, Boston, MA

1:10 PM
Updates on Smoldering Multiple Myeloma
 

IG

Irene Ghobrial, MD
Dana-Farber Cancer Institute, Boston, MA

1:25 PM
Updates in Newly Diagnosed Multiple Myeloma
 
Saad-Usmani
Saad Usmani, MD
Memorial Sloan Kettering Cancer Center, Montvale, NJ

1:40 PM
Updates on the Use of CELMoDs and Other Small-Molecule Inhibitors
 

YL

Yuxin Liu, MD
Dana-Farber Cancer Institute, Boston, MA

1:55 PM
Panel Discussion
2:40 PM
Coffee Break

Session IV: Updates on T-Cell Redirected Therapies and ADCs
Moderated by:

Noopur-Raje

Noopur Raje, MD
Massachusetts General Hospital, Boston, MA

3:00 PM
Bispecific T-Cell Engager Updates

EO

Elizabeth O'Donnell, MD
Dana-Farber Cancer Institute, Boston, MA

3:15 PM

CAR-T Cell Therapy Updates

Krina-Patel
Krina Patel, MD
MD Anderson Cancer Center, Houston, TX


3:30 PM

Updates on Novel Combinations and ADCs

Andrew-Yee
Andrew Yee, MD
Massachusetts General Hospital, Boston, MA
3:45 PM
Panel Discussion
4:30 PM
Adjourn

February 13, 2026 | Day 2

8:00 AM
Registration Opens

Session V: Updates on Aggressive and Indolent B-Cell Lymphomas
Moderated by:

Christopher-Flowers

Christopher Flowers, MD
MD Anderson Cancer Center, Houston, TX

9:00 AM

Newly Diagnosed DLBCL

Gilles-Salles
Gilles Salles, MD
Memorial Sloan Kettering Cancer Center, New York City, NY
9:15 AM

Relapsed DLBCL Combinations, Bispecific Abs

John-Leonard
John Leonard, MD
Weill Cornell Medicine, New York, NY
9:30 AM

Newly Diagnosed Follicular Lymphoma, Marginal Zone Lymphoma

FF

Fateeha Furqan, MD
MD Anderson Cancer Center, Houston, TX
9:45 AM
Panel Discussion
10:30 AM
Coffee Break

Session VI: Updates on Hodgkin, T-Cell, and Mantle Cell Lymphomas
Moderated by:

Christopher-Flowers

Christopher Flowers, MD
MD Anderson Cancer Center, Houston, TX

10:50 AM

Hodgkin Lymphoma

Alison-Moskowitz
Alison Moskowitz, MD
Memorial Sloan Kettering Cancer Center, New York, NY
11:05 AM

Peripheral T-Cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL)

Steven-Horwitz
Steven Horwitz, MD
Memorial Sloan Kettering Cancer Center, New York, NY
11:20 AM

Mantle Cell Lymphoma

Michael-Wang
Michael Wang, MD
MD Anderson Cancer Center, Houston, TX
11:35 AM
Panel Discussion
12:20 PM
Lunch Break + Faculty and Fellow Photo

Session VII: MDS
Moderated by:

RK

Rami Komrokji, MD
Moffitt Cancer Center, Tampa, FL

1:10 PM

CHIP / CCUS

Uma-Borate
Uma Borate, MD
The Ohio State University, Ohio
1:25 PM

Lower-Risk MDS

Mikkael-Sekeres
Mikkael A. Sekeres, MD
University of Miami Miller School of Medicine, Miami, FL
1:25 PM

Higher-Risk MDS

Guillermo-GarciaManero
Guillermo Garcia-Manero, MD
MD Anderson Cancer Center, Houston, TX
1:55 PM
Panel Discussion
2:40 PM
Coffee Break

Session VIII:MPN
Moderated by:

RK

Rami Komrokji, MD
Moffitt Cancer Center, Tampa, FL

3:00 PM

Myelofibrosis

Prithviraj-Bose
Prithviraj Bose, MD
MD Anderson Cancer Center, Houston, TX

3:15 PM

PV and ET

Gabriela-Hobbs-2
Gabriela Hobbs, MD
Massachusetts General Hospital, Boston, MA

3:30 PM

Mastocytosis and Other MPN

Andrew-Kuykendall
Andrew Kuykendall, MD
Moffitt Cancer Center, Tampa, FL


3:45 PM
Panel Discussion
4:30 PM
Adjourn

February 14, 2026 | Day 3

8:00 AM
Registration Opens

Session IX: ALL
Moderated by:

Elias-Jabbour

Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX

9:00 AM

Frontline ALL

Wendy-Stock
Wendy Stock, MD
The University of Chicago Medicine, Chicago, IL
9:15 AM

Relapse Refractory ALL Novel Agents

Aaron-Logan-1
Aaron Logan, MD
UCSF Helen Diller Family Comprehensive Cancer Center, CA
9:30 AM

PH+ ALL

Nicholas-Short
Nicholas Short, MD
MD Anderson Cancer Center, Houston, TX
9:45 AM

CAR-T in ALL

Jae-Park
Jae Park, MD
Memorial Sloan Kettering Cancer Center, New York City, NY
10:00 AM

T-ALL

Kristen-ODwyer
Kristen O’Dwyer, MD
University of Rochester, MN
10:15 PM
Panel Discussion
11:00 AM
Coffee Break

Session X: CML/CLL
Moderated by:

Elias-Jabbour

Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX

11:20 AM

CML Frontline

Daniel-Deangelo
Daniel DeAngelo, MD
Dana-Farber Cancer Institute, Boston, MA
11:35 AM

CML Relapse

MM

Michael Mauro, MD
Memorial Sloan Kettering Cancer Center, New York City, NY
11:50 AM

CLL Frontline

William-Wierda-1
William Wierda, MD
MD Anderson Cancer Center, Houston, TX
12:05 PM

CLL Relapse

William-Wierda-1
William Wierda, MD
MD Anderson Cancer Center, Houston, TX
12:20 PM
Panel Discussion
1:05 PM
Adjourn

Olivia Wright
Project Manager

How long has Olivia Wright been in the business?

Olivia Wright has been with MD Education since 2025.

About Olivia Wright

As an Assistant Project Manager, I support the delivery of educational events and projects at MD Education, working closely with the project management team to ensure smooth coordination and consistently high-quality execution. With a strong background in organisation and communication, I take pride in maintaining a detail-oriented approach to my work. I am committed to delivering to a high standard and value the opportunity to be part of a team dedicated to advancing clinical education.

Olivia-Wright